Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 65399 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–26084 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–14ADD] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Occupational Research 

Agenda (NORA) 2016 Decade Review— 

New—National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Institute for 

Occupational Safety and Health 

(NIOSH) is responsible for conducting 

research and making recommendations 

to prevent worker injury and illness, as 

authorized in Section 20(a)(1) of the 

Occupational Safety and Health Act (29 

U.S.C. 669). In 1995–6, NIOSH saw an 

opportunity to enhance its ability to 

accomplish its mission through 

partnerships that involved a broad 

national stakeholder base in 

occupational safety and health. With 

stakeholder input, NIOSH developed 

and launched a decade-long partnership 

program titled the National 

Occupational Research Agenda (NORA) 

in 1996. Participation in NORA includes 

stakeholders from universities, large and 

small businesses, professional societies, 

government agencies, and worker 

organizations. After an internal 

management review of the first decade 

of NORA, conducted in 2005, NIOSH 

launched the second decade of NORA 

(2006–2016) structured for even greater 

national impact. This information 

collection is a necessary part of a larger 

internal NIOSH management review of 

the second decade of NORA. The results 

of this review will inform NIOSH 

decisions about how to structure a third 

decade of NORA (2016–2026) for 

maximum effectiveness and impact. 

The second decade of NORA was 

based on a new sector structure to better 

move research to practice within 

workplaces. The work of the sectors is 

managed through a partnership 

structure of sector councils. Each 

council develops and maintains an 

agenda for the decade for its sector. The 

sector agendas become part of the 

national agenda for improvements in 

occupational safety and health through 

research and partnerships. Representing 

all stakeholders, the councils use an 

open process to set goals, develop 

strategies, encourage partnerships, and 

promote improved workplace practices. 

NIOSH is requesting a 12-month OMB 

approval to administer a survey to 

NORA council members and leaders. 

The collection of information is 

necessary for NIOSH management to 

assess the efficiency and effectiveness of 

the NORA sector councils. The target 

population is all current and former 

members and leaders of each of the ten 

NORA Sector Councils. The web-based 

questionnaire requests information on 

satisfaction with the efficiency of the 

council and its processes, on impacts 

made in the sector during the second 

decade, and suggestions for improving 

the effectiveness and impact of NORA 

in the future. Without this data 

collection, NIOSH’s internal 

management review of NORA would 

lack critical stakeholder input from its 

many non-Federal partners. 

A 16-item questionnaire has been 

developed and will be sent to all 352 

non-Federal NORA Sector council 

members or leaders. A pilot test of the 

questionnaire was conducted by asking 

eight NIOSH employees who are a 

leader of a NORA sector council to 

complete the questionnaire and provide 

feedback. Respondents to the pilot test 

estimated the questionnaire requires 

approximately 15 minutes to complete. 

The total estimated burden is 88 hours. 

There is no cost to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs.) 

Council member or leader .............................. Council Questionnaire .................................... 352 1 15/60 


rmajette on DSK3VPTVN1PROD with NOTICES
65400 Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–26132 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 9:00 a.m.–5:30 p.m. EST, 

December 4, 2014; 8:00 a.m.–12:00 p.m. EST, 

December 5, 2014. 

Place: CDC, 4770 Buford Highway, 

Chamblee Building 107 1B/1C, Atlanta, 

Georgia 30341. 

This meeting is also accessible by 

teleconference and web access. 

Teleconference and web access login 

information is as follows: 

Toll-Free Telephone: 1–800–621–3587, 

Participant passcode: 9679129. There is also 

a toll number for anyone outside of the USA: 

TOLL NUMBER: 1–517–308–9263, 

Participant passcode: 96791NET 

CONFERENCE AND WEB URL: For 

December 4, 2014: https://

www.mymeetings.com/nc/join/ Conference 

number: PW9240020, Audience passcode: 

9679129. 

For December 5, 2014: https://

www.mymeetings.com/nc/join/ Conference 

number: PW9240028, Audience passcode: 

9679129. 

Participants can join the event directly at: 

https://www.mymeetings.com/nc/

join.php?i=PW9240020&p=9679129&t=c. 

Status: Open to the public, limited only by 

the space and phone lines available. 

Purpose: The committee provides advice 

and guidance to the Secretary, HHS; the 

Assistant Secretary for Health; and the 

Director, CDC, regarding the formative 

research, development, implementation and 

evaluation of evidence-based activities 

designed to prevent breast cancer 

(particularly among those at heightened risk) 

and promote the early detection and support 

of young women who develop the disease. 

The advice provided by the Committee will 

assist in ensuring scientific quality, 

timeliness, utility, and dissemination of 

credible appropriate messages and resource 

materials. 

Matters for Discussion: The agenda will 

include discussions on the current and 

emerging topics related to breast cancer in 

young women. These may include public 

health communication, breast cancer in 

young women digital and social media 

campaigns, and CDC updates. Topics will 

address efforts increase awareness around 

breast cancer risk, breast health, symptoms, 

diagnosis, and treatment of breast cancer in 

young women. 

Agenda items are subject to change as 

priorities dictate. 

Online Registration Required: In order to 

expedite the security clearance process 

required for entry into a Federal building, all 

ACBCYW attendees must register for the 

meeting online at least 7 days in advance at 

http://www.cdc.gov/cancer/breast/what_cdc_

is_doing/meetings.htm. Please complete all 

the required fields before submitting your 

registration and submit no later than 

November 28, 2014. Each meeting day, 

attendees must provide CDC staff and 

security with driver’s license/state issued ID, 

or passport. 

Contact Person for More Information: 

Temeika L. Fairley, Ph.D., Designated Federal 

Officer, National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 5770 

Buford Hwy. NE., Mailstop K52, Atlanta, 

Georgia 30341, Telephone (770) 488–4518, 

Fax (770) 488–4760. Email: acbcyw@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and Agency for Toxic Substances 

and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26082 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases (BSC, OID); 

Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 10:00–11:00 a.m. EST, 

November 20, 2014. 

Place: Teleconference. 

Status: The meeting is open to the public; 

the toll free dial in number is 1–877–951– 

7311 with a pass code of 1588067. 

Purpose: The BSC, OID, provides advice 

and guidance to the Secretary, Department of 

Health and Human Services; the Director, 

CDC; the Director, OID; and the Directors of 

the National Center for Immunization and 

Respiratory Diseases, the National Center for 

Emerging and Zoonotic Infectious Diseases, 

and the National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, CDC, in 

the following areas: strategies, goals, and 

priorities for programs; research within the 

national centers; and overall strategic 

direction and focus of OID and the national 

centers. 

Matters for Discussion: Discussions will 

focus on current responses and national 

center priorities. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, M.A.T., Designated Federal 

Officer, OID, CDC, 1600 Clifton Road NE., 

Mailstop D10, Atlanta, Georgia 30333, 

Telephone: (404) 639–4461. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26083 Filed 11–3–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10527] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

any of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 


rmajette on DSK3VPTVN1PROD with NOTICES